1. Home
  2. NKTR vs RELL Comparison

NKTR vs RELL Comparison

Compare NKTR & RELL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NKTR
  • RELL
  • Stock Information
  • Founded
  • NKTR 1990
  • RELL 1947
  • Country
  • NKTR United States
  • RELL United States
  • Employees
  • NKTR N/A
  • RELL N/A
  • Industry
  • NKTR Biotechnology: Pharmaceutical Preparations
  • RELL Electronic Components
  • Sector
  • NKTR Health Care
  • RELL Technology
  • Exchange
  • NKTR Nasdaq
  • RELL Nasdaq
  • Market Cap
  • NKTR 247.9M
  • RELL 202.2M
  • IPO Year
  • NKTR 1994
  • RELL N/A
  • Fundamental
  • Price
  • NKTR $0.93
  • RELL $13.77
  • Analyst Decision
  • NKTR Buy
  • RELL
  • Analyst Count
  • NKTR 3
  • RELL 0
  • Target Price
  • NKTR $4.00
  • RELL N/A
  • AVG Volume (30 Days)
  • NKTR 2.3M
  • RELL 65.7K
  • Earning Date
  • NKTR 11-07-2024
  • RELL 01-08-2025
  • Dividend Yield
  • NKTR N/A
  • RELL 1.71%
  • EPS Growth
  • NKTR N/A
  • RELL N/A
  • EPS
  • NKTR N/A
  • RELL N/A
  • Revenue
  • NKTR $93,137,000.00
  • RELL $197,604,000.00
  • Revenue This Year
  • NKTR $12.85
  • RELL $15.93
  • Revenue Next Year
  • NKTR N/A
  • RELL $11.34
  • P/E Ratio
  • NKTR N/A
  • RELL N/A
  • Revenue Growth
  • NKTR 5.53
  • RELL N/A
  • 52 Week Low
  • NKTR $0.47
  • RELL $8.08
  • 52 Week High
  • NKTR $1.93
  • RELL $15.51
  • Technical
  • Relative Strength Index (RSI)
  • NKTR 33.04
  • RELL 42.82
  • Support Level
  • NKTR $0.89
  • RELL $13.82
  • Resistance Level
  • NKTR $1.04
  • RELL $15.51
  • Average True Range (ATR)
  • NKTR 0.07
  • RELL 0.52
  • MACD
  • NKTR -0.00
  • RELL -0.08
  • Stochastic Oscillator
  • NKTR 14.81
  • RELL 21.24

About NKTR Nektar Therapeutics

Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.

About RELL Richardson Electronics Ltd.

Richardson Electronics Ltd provides engineered solutions, power grid, and microwave tubes and related consumables, power conversion, RF and microwave components, high-value flat panel detector solutions, replacement parts, tubes, and service training for diagnostic imaging equipment and customized display solutions. Its products have applications in alternative energy, healthcare, aviation, broadcast, communications, industrial, marine, medical, military, scientific, and semiconductor markets. The company segments include PMT (Power and Microwave Technologies Group), Canvys, (Green Energy Solutions) GES, and Healthcare reportable segments. The company derives the majority of its revenues from the PMT segment.

Share on Social Networks: